The present invention provides a compound of formula (A): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula A, and pharmaceutical compositions comprising such compounds.本發明提供一種如本文所述之式(A)化合物,及其醫藥學上可接受之鹽、對映異構體、旋轉異構體、互變異構體或外消旋體。亦提供使用該等式(A)化合物及包含該等化合物之醫藥組合物治療由PIM激酶介導之疾病或病狀之方法。